REMSIMA® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/VIAL
Product details
Registration number: SIN14972P
Classification: Prescription Only
Active ingredients: Infliximab
Strength: 100mg/vial
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Route: INTRAVENOUS
Registrant: CELLTRION HEALTHCARE SINGAPORE PRIVATE LIMITED
ATC code: L04AB02
HSA approval date: 28 March 2016
Manufacturer(s):
- Gensenta Ilaç Sanayi ve Ticaret A.S.
- CELLTRION Inc., Plant II (CLT2)
Manufacturing country/countries: TURKEY; KOREA, REPUBLIC OF
What are the HSA registration number and classification for REMSIMA® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14972P
Classification: Prescription Only
What active ingredients and strength are recorded for REMSIMA® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Infliximab
Strength: 100mg/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for REMSIMA® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Route: INTRAVENOUS
Who is the recorded registrant for REMSIMA® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Registrant: CELLTRION HEALTHCARE SINGAPORE PRIVATE LIMITED
Which manufacturers and countries are listed for REMSIMA® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Gensenta Ilaç Sanayi ve Ticaret A.S.
- CELLTRION Inc., Plant II (CLT2)
Manufacturing country/countries: TURKEY; KOREA, REPUBLIC OF
Where can I look up REMSIMA® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/VIAL in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14972P or the exact product name REMSIMA® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/VIAL. The general register link does not preselect this product.
What are the source dates for this REMSIMA® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/VIAL record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this REMSIMA® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/VIAL record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14972P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)